This observation has raised concerns regarding suboptimal drug exposure, altered pharmacokinetics, and heightened inflammatory burden in obese patients, highlighting the potential need for dose optimization or alternative treatment strategies in this population ( The impact of BMI on treatment response is well illustrated by the AQUILA study, which examined real-world outcomes in PsA patients treated with (65).In this cohort, obese individuals exhibited higher circulating levels of IL-17, supporting the concept that IL-17driven inflammation may be particularly prominent in this subgroup and may contribute to increased disease activity and reduced therapeutic responsiveness (66)
Insulin resistance is a condition in which the bodys cells become resistant to the effects of insulin, a hormone produced by the pancreas that regulates blood sugar levels
But, if you find down the road issues with dose escalation, or other side effects that seem to be gradually building like the ones I mentioned
It is also closely linked to deep sleep cycles, which are essential for recovery, hormonal balance, and cellular regeneration, contributing to both aesthetic and wellness-focused benefits
No unwanted ingredients or fillers added
EMBO Journal 16, 15011507
